MAPT and tauopathy: PERK was identified as a genetic risk factor in several tauopathies (Yuan et al., 2018), inhibiting PERK prevents tau‐mediated neurodegeneration in rTg4510 mice (Radford, Moreno, Verity, Halliday, & Mallucci, 2015).